Clinical Advisory Group

Professor Peter Richmond, Co-Chair

Professor Peter Richmond is Co-Chair of the VISTA Clinical Advisory Group and serves as Co-Lead of the Vaccine Trials Group (VTG) at the Wesfarmers Centre of Vaccines & Infectious Diseases, Consultant Paediatric Immunologist and Paediatrician at Perth Children’s Hospital, Child and Adolescent Health Service, and Professor and Head of Paediatrics at the University of Western Australia Medical School. He is an internationally recognised clinician-researcher with extensive expertise in paediatric immunology, vaccine development, and clinical trials for 30 years. His particular research and clinical interests include viral and bacterial respiratory infections, meningitis, otitis media, maternal and childhood vaccination, vaccine safety, and immunisation policy, having served on ATAGI for 10 years. Throughout his career, Professor Richmond has led and contributed to numerous vaccine studies and clinical trials, helping to advance evidence-based immunisation practice and improve child health outcomes nationally and internationally.

Dr Cheryl Keech, Co-Chair and Scientific Advisory Board Member

Dr Cheryl Keech is a global vaccine development expert and member of the Scientific Advisory Board, with extensive experience leading vaccine clinical development programs across the pharmaceutical, biotechnology, contract research, and non-government sectors. Her expertise spans strategic product development, innovative clinical trial design, assay development, regulatory engagement, pharmacovigilance, and health technology assessment. Having worked across multiple vaccine platforms and international markets, she has guided vaccine programs through all stages of development, from pre-licensure to post-licensure. Dr Keech is recognised for her collaborative leadership, commitment to scientific excellence, and dedication to advancing equitable access to vaccines and improved global health outcomes. As Co-Chair of the Clinical Advisory Group, she brings deep clinical development expertise and helps ensure strategic alignment between the Clinical Advisory Group and Scientific Advisory Board.